Brief: Edgewise Therapeutics Q4 Basic EPS USD -0.42
03/03/2025 13:00
Mar 03 (Reuters) - Edgewise Therapeutics Q4 operating income USD -45.54 million. Q4 operating expenses USD 45.54 million Q4 net income USD -39.662 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending